MEDIFAST INC
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
MED$13.37+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Numberof SharesIssued · CommonStock · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · RetainedEarnings · TreasuryStock · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Balance, January 1, 2021 | 11,822 | $12 | $7,842 | $41 | $154,351 | $(5,000) | $157,246 | ||
| Net income | — | — | — | — | 164,031 | — | 164,031 | ||
| Share-based compensation | 55 | — | 9,454 | — | 142 | — | 9,596 | ||
| Options exercised by executives and directors | 29 | — | 811 | — | — | — | 811 | ||
| Net shares repurchased for taxes | (28) | — | (6,089) | — | — | — | (6,089) | ||
| Treasury stock from stock repurchases | — | — | — | — | — | (55,999) | (55,999) | ||
| Treasury stock retired from stock repurchases | (284) | — | — | — | (60,999) | 60,999 | — | ||
| Other comprehensive income | — | — | — | 70 | — | — | 70 | ||
| Cash dividends declared to stockholders | — | — | — | — | (67,192) | — | (67,192) | ||
| Balance, December 31, 2021 | 11,594 | $12 | $12,018 | $111 | $190,333 | $— | $202,474 | ||
| Net income | — | — | — | — | 143,568 | — | 143,568 | ||
| Share-based compensation | 20 | — | 11,053 | — | — | — | 11,053 | ||
| Net shares repurchased for taxes | (9) | — | (1,516) | — | — | — | (1,516) | ||
| Treasury stock from stock repurchases | — | — | — | — | — | (126,445) | (126,445) | ||
| Treasury stock retired from stock repurchases | (677) | (1) | — | — | (120,047) | 120,047 | (1) | ||
| Other comprehensive income | — | — | — | (87) | — | — | (87) | ||
| Cash dividends declared to stockholders | — | — | — | — | (74,002) | — | (74,002) | ||
| Balance, December 31, 2022 | 10,928 | $11 | $21,555 | $24 | $139,852 | $(6,398) | $155,044 | ||
| Net income | — | — | — | — | 99,415 | — | 99,415 | ||
| Share-based compensation | 76 | — | 8,188 | — | — | — | 8,188 | ||
| Options exercised by executives and directors | 7 | — | 188 | — | — | — | 188 | ||
| Net shares repurchased for taxes | (31) | — | (3,358) | — | — | (3,358) | |||
| Treasury stock from stock repurchases | — | — | — | — | — | (3,602) | (3,602) | ||
| Treasury stock retired from stock repurchases | (84) | — | — | — | (10,000) | 10,000 | — | ||
| Other comprehensive income | — | — | — | 224 | — | — | 224 | ||
| Cash dividends declared to stockholders | — | — | — | — | (54,618) | — | (54,618) | ||
| Balance, December 31, 2023 | 10,896 | $11 | $26,573 | $248 | $174,649 | $— | $201,481 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.